Getting to value in healthcare has proven to be difficult, but succesful programs have certain characteristics, said David Blumenthal, MD, MPP, president of The Commonwealth Fund.
Getting to value in healthcare has proven to be difficult, but succesful programs have certain characteristics, said David Blumenthal, MD, MPP, president of The Commonwealth Fund.
Transcript
As the healthcare industry continues to move toward value-based care, what best practices have come to light?
Getting the value is hard we’ve discovered in a number of best practices. We think that when providers and payers are closely aligned, that there tends to be an environment in which value is easier to achieve. An example of those are Geissinger and Kaiser and Henry Ford. We’ve also found in our work on high-need, high-cost patients that there are certain characteristics of successful programs that manage that very important population that seem to be found in common among successful programs. For example, the use of information technology to inform care, the use of teams, engagement of patients and segmentation of patients to identify those who need different types of care. I think we’re making progress overall, there’s no question that it’s hard work and there’s a lot more work to do.
What are the biggest challenges you’ve seen in the move toward value-based care?
Well one is measurement. It’s hard to measure quality and controversy and burden associated with it and a recognition that sometimes the measures produce selection of patients that’s not good for high-risk patients and low income patients. That’s one important challenge. The other is getting past fee-for-service and getting to a place where accountability for cost and quality are married in the same organizations. And the third is getting those organizations to have the right sills and the right technology so they can effectively manage and be accountable for the candidate provide.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Specialty Drug Users to Gain Relief Under Medicare Reforms
May 16th 2025A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often represent a significant cost burden for Medicare Part D beneficiaries and which were selected for 2026 drug price negotiation under the Inflation Reduction Act.
Read More
RFK Jr Claims HHS Has Not Fired Working Scientists, Canceled Lifesaving Research
May 15th 2025Robert F. Kennedy Jr’s congressional hearing featured numerous statements from the secretary of HHS, including denouncing claims of cutting down the HHS and the National Institutes of Health.
Read More
Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits
May 15th 2025Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.
Read More